Structure-activity relationship for DNA topoisomerase II-induced DNA cleavage by azatoxin analogues
Authors:
- Jetze J. TepeJTJetze J. Tepe
- Karl A. WerbovetzKWKarl A. Werbovetz
- Erich K. LehnertELErich K. Lehnert
- Timothy L. MacdonaldTMTimothy L. Macdonald
- 1 September 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 5 (9) , 1807-1815
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Inhibition of DNA Topoisomerase II by Azaelliptitoxins Functionalized in the Variable Substituent DomainJournal of Medicinal Chemistry, 1996
- Cellular pharmacology of azatoxins (topoisomerase‐II and tubulin inhibitors) in P‐glycoprotein‐positive and ‐negative cell linesInternational Journal of Cancer, 1995
- Azatoxin derivatives with potent and selective action on topoisomerase IIBiochemical Pharmacology, 1995
- Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agentBiochemical Pharmacology, 1993
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Synthesis and antitumor activity of podophyllotoxin aza-analoguesTetrahedron Letters, 1989
- A consensus sequence for cleavage by vertebrate DNA topoisomerase IINucleic Acids Research, 1988
- Exceptional stereochemical control in the Pictet-Spengler reactionTetrahedron Letters, 1987
- DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyPharmacology & Therapeutics, 1987
- Study of the Pictet-Spengler reaction in aprotic media: synthesis of the .beta.-galactosidase inhibitor, pyridindololThe Journal of Organic Chemistry, 1979